204 related articles for article (PubMed ID: 11750333)
1. Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(0)) and C(2) concentrations in stable renal allograft recipients.
Einecke G; Mai I; Diekmann F; Fritsche L; Boehler T; Neumayer HH; Budde K
Transplant Proc; 2001; 33(7-8):3102-3. PubMed ID: 11750333
[No Abstract] [Full Text] [Related]
2. Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipients.
Einecke G; Mai I; Diekmann F; Fritsche L; Neumayer HH; Budde K
Transplant Proc; 2002 Aug; 34(5):1738-9. PubMed ID: 12176557
[No Abstract] [Full Text] [Related]
3. Safety and efficacy of conversion from once daily Sandimmun to twice daily Neoral cyclosporine in renal allograft recipients.
Vathsala A; Lee WT; Lu YM; Woo KT
Transplant Proc; 1998 Aug; 30(5):1746-8. PubMed ID: 9723264
[No Abstract] [Full Text] [Related]
4. Neoral drug monitoring in stable kidney allotransplant recipients: C(0) versus C(2).
Lukaschek J; Hofmann J; Aerne D; Ambühl P; Kistler T; Knoflach A; Pei P; Binswanger U
Transplant Proc; 2001; 33(7-8):3104-5. PubMed ID: 11750334
[No Abstract] [Full Text] [Related]
5. Cyclosporine A: peak or trough level monitoring in renal transplant recipients?
Wacke R; Drewelow B; Kundt G; Hehl EM; Bast R; Seiter H
Transplant Proc; 2001; 33(7-8):3122-3. PubMed ID: 11750342
[No Abstract] [Full Text] [Related]
6. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
Roth D; Miller J
Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
[No Abstract] [Full Text] [Related]
7. Conventional versus Neoral cyclosporine in renal transplantation.
Rovelli E; Bucci A; Maldifassi P; Belfiore A; D'Amico G
Transplant Proc; 1998 Aug; 30(5):1764-5. PubMed ID: 9723272
[No Abstract] [Full Text] [Related]
8. Pharmacokinetic study of twice vs thrice daily dosing of Sandimmun Neoral in pediatric renal transplant patients.
Papachristou F; Gakis D; Sotiriou I; Liatsis I; Takoudas D; Antoniadis A
Transplant Proc; 1998 Aug; 30(5):1988-90. PubMed ID: 9723363
[No Abstract] [Full Text] [Related]
9. Sandimmun and Neoral treatment: pharmacokinetics and kidney function in paediatric and adolescent renal transplant.
De Palma MT; Giordano M; Colella V; Palumbo F; De Nicolo VE; Caringella DA
Transplant Proc; 1998 Aug; 30(5):1677. PubMed ID: 9723239
[No Abstract] [Full Text] [Related]
10. Estimated area-under-the-curve monitoring of Neoral in a stable pediatric renal transplant population: one-year experience.
Lemire J; Capparelli EV; MacDonald D; Benador N; Reznik VM; Mendoza SA; Griswold WR
Transplant Proc; 1998 Aug; 30(5):1983-4. PubMed ID: 9723361
[No Abstract] [Full Text] [Related]
11. Time-dependent difference of the 12-hour trough levels of cyclosporine in renal transplant recipients with sandimmune capsule.
To H; Haba T; Uchida K; Fujimura A; Kobayashi E
Transplant Proc; 2000 Feb; 32(1):221-2. PubMed ID: 10701028
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics of abbreviated AUC of cyclosporine in renal allograft recipients in a Pakistani population.
Zafar MN; Abbas K; Naqvi A; Rizvi A
Transplant Proc; 1999 Dec; 31(8):3304. PubMed ID: 10616486
[No Abstract] [Full Text] [Related]
13. Study of neoral kinetics in adult renal transplantation treated with diltiazem.
Mezzano S; Flores C; Ardiles L; Foradori A; Elberg A
Transplant Proc; 1998 Aug; 30(5):1660-2. PubMed ID: 9723232
[No Abstract] [Full Text] [Related]
14. Improvement of correlation between oral dose of cyclosporine and cyclosporinemia after substitution of cyclosporine standard presentation by cyclosporine microemulsion one, in 1345 patients with kidney transplantation. Spanish Sandimmune Neoral Conversion Group.
Gentil Govantes MA; Gómez Ullate P; Errasti P; Fernández Fresnedo G; Capdevila L; Sanz Guajardo A; Cubero JJ
Transplant Proc; 1998 Aug; 30(5):1658-9. PubMed ID: 9723231
[No Abstract] [Full Text] [Related]
15. Cyclosporine pharmacokinetic profiles in stable renal allograft recipients converting from Sandimmun to Neoral.
Vathsala A; Lee WT; Jacob E; Woo KT
Transplant Proc; 1996 Jun; 28(3):1324-6. PubMed ID: 8658678
[No Abstract] [Full Text] [Related]
16. Neoral (cyclosporine) C2 monitoring in renal transplant recipients: a single-center experience in Asia.
Wong HS; Morad Z
Transplant Proc; 2003 Feb; 35(1):230-1. PubMed ID: 12591376
[No Abstract] [Full Text] [Related]
17. A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
Foradori A; Pinto VM; Elberg A
Transplant Proc; 1998 Aug; 30(5):1666-7. PubMed ID: 9723235
[No Abstract] [Full Text] [Related]
18. Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.
Foradori A; Mezzano S; Videla C; Pefaur J; Elberg A
Transplant Proc; 1998 Aug; 30(5):1685-7. PubMed ID: 9723244
[No Abstract] [Full Text] [Related]
19. Cyclosporine Neoral profiling in Japanese renal transplant recipients.
Aikawa A; Arai K; Tajima E; Kawamura T; Ogiwara H; Sakai K; Mizuiri S; Ohara T; Hasegawa A; Kosugi T; Kusano A; Matsuo K; Obayashi M; Kurokawa M
Transplant Proc; 2001; 33(7-8):3142-5. PubMed ID: 11750350
[No Abstract] [Full Text] [Related]
20. Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral.
Warrens AN; Salama A; Waters JB; Lechler RI
Transplant Proc; 1996 Aug; 28(4):2169-70. PubMed ID: 8769190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
